Table 4 Baseline values and change after 12 months of outcome measures in intervention and usual care groups for the patients having hypertension, ischemic heart disease and diabetes

0.880 (0.083)

0.891 (0.082)

0.007 (−0.004 to 0.017)

− 0.001 (− 0.011 to 0.10)

0.34

0.52

27.9 (4.6)

27.9 (5.0)

0.06 (−0.24 to 0.35)

−0.04 (− 0.24 to 0.16)

0.59

0.58

3.04 (0.95)

2.95 (0.93)

−0.07 (− 0.23 to 0.09)

0.05 (− 0.10 to 0.20)

0.27

0.37

36.8 (4.3)

37.9 (3.6)

0.6 (0.1 to 1.0)

0.3 (0.1 to1.0)

0.41

0.98

144 (16)

144 (17)

−4.2 (−8.0 to −0.4)

− 4.0 (−7.1 to −1.0)

0.95

0.65

83 (10)

85 (11)

−2.0 (−4.0 to −0.0)

− 2.2 (−3.9 to − 0.5)

0.91

0.64

105 (11)

106 (11)

−2.7 (−5.1 to −0.4)

−2.8 (− 4.7 to − 0.9)

0.97

0.62

0.860 (0.085)

0.860 (0.106)

0.001 (−0.014 to 0.015)

−0.012 (− 0.029 to 0.005)

0.28

0.28

28.1 (4.4)

28.3 (5.5)

−0.40 (− 0.87 to 0.08)

−0.20 (− 0.49 to 0.09)

0.47

0.40

2.21 (0.74)

2.23 (0.80)

0.09 (−0.09 to 0.27)

0.05 (−0.12 to 0.22)

0.77

0.78

38.5 (3.9)

38.3 (4.7)

0.7 (0.1 to 1.4)

0.3 (−0.4 to 1.0)

0.40

0.31

144 (19)

143 (16)

−3.1 (−7.5 to 1.3)

−0.1 (−4.4 to 4.3)

0.33

0.87

82 (11)

79 (9)

−1.5 (−4.2 to 1.2)

−0.7 (−3.3 1.9)

0.65

0.83

103 (11)

100 (10)

−2.1 (−4.8 to 0.7)

−0.5 (−3.2 to 2.2)

0.42

0.74

0.856 (0.108)

0.868 (0.096)

0.002 (−0.010 to 0.013)

0.001 (−0.010 to 0.012)

0.91

0.84

31.0 (5.5)

31.6 (6.2)

−0.30 (− 0.54 to − 0.07)

0.03 (− 0.26 to 0.32)

0.081

0.078

2.49 (0.94)

2.38 (0.83)

0.03 (−0.10 to 0.15)

0.07 (−0.04 to 0.19)

0.61

0.74

45.6 (9.7)

46.7 (10.9)

0.2 (−0.8 to 1.3)

−0.1 (−1.4 to 1.3)

0.75

0.91

145 (19)

144 (17)

−2.4 (−6.1 to 1.3)

1.9 (−5.4 to 1.5)

0.86

0.54

81 (12)

80 (10)

−0.1 (−2.1 to 1.9)

−0.1 (−1.9 to 1.6)

0.97

0.81

102 (12)

101 (10)

−0.9 (−3.2 to 1.4)

− 0.7 (−2.9 to 1.4)

0.94

0.89